Praxis Precision Medicines Inc (PRAX) — Financial Flexibility Index
Praxis Precision Medicines Inc (PRAX) has a Financial Flexibility Index of -1.71x as of March 2026. Free cash flow of $-85.99 Million (operating CF $-86.05 Million minus capex $62.00K) represents -2% of total liabilities ($50.24 Million). Check PRAX PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Praxis Precision Medicines Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Praxis Precision Medicines Inc across 8 annual periods. See Praxis Precision Medicines Inc (PRAX) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Praxis Precision Medicines Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Praxis Precision Medicines Inc. For the full company profile including market capitalisation, see Praxis Precision Medicines Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.17x | $-249.01 Million | $-249.07 Million | $59.77 Million | ▼ -19.1% |
| 2024 | -3.50x | $-131.76 Million | $-131.76 Million | $37.66 Million | ▲ +42.4% |
| 2023 | -6.08x | $-111.09 Million | $-111.14 Million | $18.28 Million | ▼ -28.5% |
| 2022 | -4.73x | $-184.60 Million | $-185.04 Million | $39.02 Million | ▼ -60.6% |
| 2021 | -2.95x | $-123.50 Million | $-124.55 Million | $41.94 Million | ▲ +12.0% |
| 2020 | -3.35x | $-52.62 Million | $-52.62 Million | $15.72 Million | ▲ +22.4% |
| 2019 | -4.31x | $-32.68 Million | $-32.79 Million | $7.58 Million | ▼ -7.4% |
| 2018 | -4.01x | $-20.66 Million | $-20.72 Million | $5.15 Million | — |